Align Technology, Inc. (0HCK.L)
USD 170.27
(2.69%)
USD 170.27
(2.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 643.33 Million USD | -1.64% |
| 2022 | 654.04 Million USD | -33.01% |
| 2021 | 976.4 Million USD | 152.19% |
| 2020 | 387.17 Million USD | -24.75% |
| 2019 | 514.48 Million USD | 10.27% |
| 2018 | 466.56 Million USD | 31.94% |
| 2017 | 353.61 Million USD | 42.06% |
| 2016 | 248.92 Million USD | 31.96% |
| 2015 | 188.63 Million USD | -2.55% |
| 2014 | 193.57 Million USD | 20.07% |
| 2013 | 161.22 Million USD | 31.2% |
| 2012 | 122.88 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 162.45 Million USD | 10.42% |
| 2024 Q1 | 154.13 Million USD | -16.62% |
| 2024 Q2 | 147.04 Million USD | -4.6% |
| 2023 Q4 | 184.86 Million USD | 11.13% |
| 2023 FY | 656.65 Million USD | 0.4% |
| 2023 Q1 | 133.51 Million USD | 7.58% |
| 2023 Q2 | 171.93 Million USD | 28.77% |
| 2023 Q3 | 166.34 Million USD | -3.25% |
| 2022 Q4 | 124.11 Million USD | -13.6% |
| 2022 Q3 | 143.65 Million USD | -23.67% |
| 2022 FY | 654.04 Million USD | -33.01% |
| 2022 Q1 | 198.08 Million USD | -10.33% |
| 2022 Q2 | 188.19 Million USD | -4.99% |
| 2021 Q3 | 261.16 Million USD | -2.88% |
| 2021 Q4 | 220.89 Million USD | -15.42% |
| 2021 Q1 | 225.44 Million USD | 5.75% |
| 2021 Q2 | 268.9 Million USD | 19.28% |
| 2021 FY | 976.4 Million USD | 152.19% |
| 2020 Q1 | 69.91 Million USD | -53.74% |
| 2020 Q3 | 177.06 Million USD | 342.56% |
| 2020 FY | 387.17 Million USD | -24.75% |
| 2020 Q4 | 213.18 Million USD | 20.4% |
| 2020 Q2 | -73 Million USD | -204.41% |
| 2019 FY | 514.48 Million USD | 10.27% |
| 2019 Q4 | 151.15 Million USD | 25.58% |
| 2019 Q3 | 120.36 Million USD | -4.09% |
| 2019 Q1 | 117.48 Million USD | -2.48% |
| 2019 Q2 | 125.49 Million USD | 6.82% |
| 2018 Q2 | 122.69 Million USD | 24.95% |
| 2018 Q1 | 98.19 Million USD | -10.41% |
| 2018 FY | 466.56 Million USD | 31.94% |
| 2018 Q4 | 120.47 Million USD | -3.78% |
| 2018 Q3 | 125.2 Million USD | 2.05% |
| 2017 Q4 | 109.6 Million USD | 10.98% |
| 2017 Q1 | 61.67 Million USD | -9.8% |
| 2017 FY | 353.61 Million USD | 42.06% |
| 2017 Q2 | 83.56 Million USD | 35.5% |
| 2017 Q3 | 98.76 Million USD | 18.18% |
| 2016 Q2 | 65.13 Million USD | 22.13% |
| 2016 Q1 | 53.33 Million USD | -10.12% |
| 2016 Q3 | 62.07 Million USD | -4.69% |
| 2016 FY | 248.92 Million USD | 31.96% |
| 2016 Q4 | 68.37 Million USD | 10.14% |
| 2015 Q2 | 42.32 Million USD | -13.49% |
| 2015 Q4 | 59.33 Million USD | 55.97% |
| 2015 FY | 188.63 Million USD | -2.55% |
| 2015 Q3 | 38.04 Million USD | -10.11% |
| 2015 Q1 | 48.92 Million USD | -4.99% |
| 2014 FY | 193.57 Million USD | 20.07% |
| 2014 Q2 | 48.73 Million USD | 16.57% |
| 2014 Q1 | 41.8 Million USD | -21.01% |
| 2014 Q4 | 51.49 Million USD | -0.1% |
| 2014 Q3 | 51.54 Million USD | 5.78% |
| 2013 Q2 | 37.9 Million USD | 30.97% |
| 2013 FY | 161.22 Million USD | 31.2% |
| 2013 Q1 | 28.93 Million USD | -2.88% |
| 2013 Q3 | 41.46 Million USD | 9.4% |
| 2013 Q4 | 52.92 Million USD | 27.63% |
| 2012 Q4 | 29.79 Million USD | 0.0% |
| 2012 FY | 122.88 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 588.217% |
| Accuray Incorporated | 504 Thousand USD | -127546.429% |
| Elevance Health Inc. | 133.96 Billion USD | 99.52% |
| AxoGen, Inc. | -21.46 Million USD | 3097.568% |
| Boston Scientific Corporation | 2.34 Billion USD | 72.542% |
| CVS Health Corporation | 13.74 Billion USD | 95.319% |
| Cardinal Health, Inc. | 1.24 Billion USD | 48.243% |
| Centene Corporation | 2.93 Billion USD | 78.043% |
| DaVita Inc. | 1.6 Billion USD | 59.861% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 93.317% |
| Hologic, Inc. | 970.2 Million USD | 33.69% |
| Humana Inc. | 4.01 Billion USD | 83.969% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 41.362% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 11.337% |
| Masimo Corporation | 136.5 Million USD | -371.31% |
| McKesson Corporation | 3.9 Billion USD | 83.542% |
| Patterson Companies, Inc. | 252.92 Million USD | -154.36% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 49.022% |
| ResMed Inc. | 1.31 Billion USD | 51.258% |
| Henry Schein, Inc. | 615 Million USD | -4.608% |
| Teladoc Health, Inc. | -248.55 Million USD | 358.833% |
| Universal Health Services, Inc. | 1.17 Billion USD | 45.266% |
| Veeva Systems Inc. | 429.33 Million USD | -49.846% |
| Baxter International Inc. | 390 Million USD | -64.958% |
| Becton, Dickinson and Company | 2.11 Billion USD | 69.524% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 63.587% |
| Danaher Corporation | 5.38 Billion USD | 88.044% |
| Stryker Corporation | 3.88 Billion USD | 83.453% |
| Medtronic plc | 5.14 Billion USD | 87.493% |